Etiology and pathogenesis of Parkinson's disease
- PMID: 21626550
- DOI: 10.1002/mds.23732
Etiology and pathogenesis of Parkinson's disease
Abstract
The past 25 years have seen a major expansion of knowledge concerning the cause of Parkinson's disease provided by an understanding of environmental and genetic factors that underlie the loss of nigral dopaminergic neurons. Based on the actions of toxins, postmortem investigations, and gene defects responsible for familial Parkinson's disease, there is now a general consensus about the mechanisms of cell death that contribute to neuronal loss in Parkinson's disease. Mitochondrial dysfunction, oxidative stress, altered protein handling, and inflammatory change are considered to lead to cell dysfunction and death by apoptosis or autophagy. Ageing is the single most important risk factor for Parkinson's disease, and the biochemical changes that are a consequence of aging amplify these abnormalities in Parkinson's disease brain. What remains to be determined is the combination and sequence of events leading to cell death and whether this is identical in all brain regions where pathology occurs and in all individuals with Parkinson's disease. Focusing on those events that characterize Parkinson's disease, namely, mitochondrial dysfunction and Lewy body formation, may be the key to further advancing the understanding of pathogenesis and to taking these mechanisms forward as a means of defining targets for neuroprotection.
Copyright © 2011 Movement Disorder Society.
Similar articles
-
In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease.Parkinsonism Relat Disord. 2013 Jan;19(1):47-52. doi: 10.1016/j.parkreldis.2012.07.002. Epub 2012 Jul 26. Parkinsonism Relat Disord. 2013. PMID: 22841687
-
[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62. Rinsho Shinkeigaku. 2004. PMID: 15287506 Review. Japanese.
-
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6. Brain. 2005. PMID: 16000336
-
Heredity in Parkinson's disease: new findings.Isr Med Assoc J. 2001 Jun;3(6):435-8. Isr Med Assoc J. 2001. PMID: 11433638 Review.
-
Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?Mov Disord. 2013 Jan;28(1):31-40. doi: 10.1002/mds.25373. Mov Disord. 2013. PMID: 23390095 Review.
Cited by
-
Differential impairment of catecholaminergic cell maturation and survival by genetic mitochondrial complex II dysfunction.Mol Cell Biol. 2012 Aug;32(16):3347-57. doi: 10.1128/MCB.00128-12. Epub 2012 Jun 18. Mol Cell Biol. 2012. PMID: 22711987 Free PMC article.
-
Considerations for measuring iron in post-mortem tissue of Parkinson's disease patients.J Neural Transm (Vienna). 2012 Dec;119(12):1515-21. doi: 10.1007/s00702-012-0898-4. Epub 2012 Sep 13. J Neural Transm (Vienna). 2012. PMID: 22972672 Review.
-
Induced pluripotent stem cells to model and treat neurogenetic disorders.Neural Plast. 2012;2012:346053. doi: 10.1155/2012/346053. Epub 2012 Jul 19. Neural Plast. 2012. PMID: 22888453 Free PMC article. Review.
-
Starting with 24-h levodopa carbidopa intestinal gel at initiation in a large cohort of advanced Parkinson's disease patients.Sci Rep. 2024 Feb 14;14(1):3676. doi: 10.1038/s41598-024-54299-z. Sci Rep. 2024. PMID: 38355970 Free PMC article.
-
Glucocerebrosidase and Parkinson disease: Recent advances.Mol Cell Neurosci. 2015 May;66(Pt A):37-42. doi: 10.1016/j.mcn.2015.03.013. Epub 2015 Mar 20. Mol Cell Neurosci. 2015. PMID: 25802027 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous